Endogena finalises enrolment for retinitis pigmentosa trial

The treatment is a small molecule that activates endogenous retinal stem and progenitor cells - News - PharmaTimes

Related Keywords

Matthias Steger ,Infocus Clinical Research ,Endogena Therapeutics ,Infocus Clinical ,Endogena ,Retinitis ,Pigmentosa ,